Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

SMG 1283.9

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS

FOOD AND DRUG ADMINISTRATION

OFFICE OF THE CHIEF SCIENTIST

NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH

OFFICE OF RESEARCH

DIVISION OF NEUROTOXICOLOGY

Effective Date: 07/08/2011

[PDF Version]

1. DIVISION OF NEUROTOXICOLOGY (DAECCF)

A. Develops and validates quantitative biomarkers of neurotoxicity and utilizes these biomarkers to clarify mechanisms of neurotoxicity

B. Develops a multidisciplinary approach that integrates neurohistological, neurochemical, neurophysiological, and behavioral assessments to determine effects and mechanisms in neurotoxicology

C. Determines target tissue concentrations and cellular interactions of neurotoxicants

D. Reduces the uncertainty of extrapolation of neurotoxicity across species by using rodent and nonhuman primate animal models and comparing the results to humans when possible

E. Administers and has lead scientific responsibilities for NCTR’s Neurotoxicology Program

2. AUTHORITY AND EFFECTIVE DATE

The functional statements for this Division were approved by the Secretary of Health and Human Services, effective July 8, 2011.

STATUS (I, R, C)DATE APPROVEDLOCATION
OF CHANGE HISTORY		CONTACTAPPROVING OFFICIAL
Initial07/08/2011N/aOO/OMSecretary of the Department of Health and Human Services
-
-
-
-